Specialists share pearls on using cenegermin, selecting patients

Eye drops containing a novel recombinant human nerve growth factor can now be used in U.S. patients to treat neurotrophic keratitis, a rare disease for which no treatment was previously available.
β€œIt is a breakthrough therapy for a degenerative disease that is rare but eventually leads to loss of vision if untreated. Now that we have this new option available, doctors need to be aware of this condition, learn to recognize it and treat it early,” Healio/OSN Board Member Kenneth A. Beckman, MD, said.
Neurotrophic keratitis results from the impairment (Read more...)

Full Story β†’